Jacobs Levy Equity Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Jacobs Levy Equity Management's HALO Position: Q1 2026 in Review
Jacobs Levy Equity Management reduced its Halozyme (HALO) stake by 10% in Q1 2026, selling an estimated $6.17M and leaving 789,429 shares worth $51M. The position accounts for 0.21% of the portfolio, ranked #115.
Jacobs Levy Equity Management first reported a position in HALO in Q2 2015 and has held it in 21 quarters since. The position peaked at $65.9M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Jacobs Levy Equity Management held 789,429 shares of Halozyme worth $51M as of Q1 2026.
- Jacobs Levy Equity Management sold 87,528 Halozyme shares in Q1 2026, an estimated $6.17M.
- Halozyme made up 0.21% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #115 holding.
- Jacobs Levy Equity Management first reported a position in Halozyme in Q2 2015 and has held it in 21 quarters since.
- Jacobs Levy Equity Management's Halozyme position peaked at $65.9M in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.